Eating more nuts is associated with reduced risk of cardiovascular disease (CVD), cancer and all-cause mortality, according to new research.
In a systematic review and dose-response meta-analysis of prospective studies, researchers looked at the association of nut consumption and risk of CVD, total cancer, and all-cause and cause-specific mortality in adults. Higher nut intake (15-20 g/day or 5-6 servings/week) was associated with reduced risk of CVD, total cancer and all-cause mortality. Both tree nut and peanut consumption resulted in similar findings.
The international team, from Norway, the UK and the U.S., analysed 20 studies into nut intake and various diseases. The findings were consistent with previous published reviews and meta-analyses, providing further evidence that higher nut intake may help to reduce the risk of CVD, total cancer and all-cause mortality.
According to the World Health Organization, CVD was the leading cause of noncommunicable disease (NCD) deaths in 2012 and was responsible for 17.5 million deaths (46%) of NCD deaths.
Aditionally, the recent results of a clinical trial, published in Metabolic Syndrome and Related Disorders, found positive benefits associated with eating almonds. The team of researchers from India examined the effects of daily consumption of almonds for 24 weeks among type-2 diabetes patients. The incorporation of almonds in a well-balanced diet was associated with multiple beneficial effects on glycemic and CVD risk factors. The study found significant improvement in mean values of waist circumference, waist-to-height ratio, serum triglycerides and low-density lipoprotein cholesterol, among other parameters.